![Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML](https://www.mdpi.com/medicina/medicina-56-00145/article_deploy/html/images/medicina-56-00145-g001.png)
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML
Atypical Relapsing Course of Kawasaki Disease with Hemorrhagic Serous Effusions and Hepatic Dysfunction
![Unlikely association between Kawasaki disease and intracranial aneurysms: a prospective cohort study in: Journal of Neurosurgery: Pediatrics Volume 23 Issue 5 (2019) Unlikely association between Kawasaki disease and intracranial aneurysms: a prospective cohort study in: Journal of Neurosurgery: Pediatrics Volume 23 Issue 5 (2019)](https://thejns.org/pediatrics/cover/journals/j-neurosurg-pediatr/23/5/cover.jpg)
Unlikely association between Kawasaki disease and intracranial aneurysms: a prospective cohort study in: Journal of Neurosurgery: Pediatrics Volume 23 Issue 5 (2019)
![PDF) Grisel syndrome as a complication of Kawasaki disease: A case report and review of the literature PDF) Grisel syndrome as a complication of Kawasaki disease: A case report and review of the literature](https://i1.rgstatic.net/publication/232249651_Grisel_syndrome_as_a_complication_of_Kawasaki_disease_A_case_report_and_review_of_the_literature/links/00b7d5278504b43f98000000/largepreview.png)
PDF) Grisel syndrome as a complication of Kawasaki disease: A case report and review of the literature
![CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE](https://www.scielo.br/img/revistas/rpp/v39//1984-0462-rpp-39-e2020217-gf1.png)
CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE
![Atypical Kawasaki Disease in 2-Months Old Infant Presenting with Aseptic Meningitis | Semantic Scholar Atypical Kawasaki Disease in 2-Months Old Infant Presenting with Aseptic Meningitis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6eb2b942d0372133541864eaea906fa690a3a2d1/3-Table4-1.png)
Atypical Kawasaki Disease in 2-Months Old Infant Presenting with Aseptic Meningitis | Semantic Scholar
![Children | Free Full-Text | Neurological Complications and Associated Risk Factors in Children Affected with Chronic Kidney Disease Children | Free Full-Text | Neurological Complications and Associated Risk Factors in Children Affected with Chronic Kidney Disease](https://www.mdpi.com/children/children-07-00059/article_deploy/html/images/children-07-00059-g001.png)
Children | Free Full-Text | Neurological Complications and Associated Risk Factors in Children Affected with Chronic Kidney Disease
![Cerebrovascular and Other Neurologic Complications of Kawasaki Disease (Chapter 6) - Uncommon Causes of Stroke Cerebrovascular and Other Neurologic Complications of Kawasaki Disease (Chapter 6) - Uncommon Causes of Stroke](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20180606093819339-0424:9781316551684:14744tbl6_1.png?pub-status=live)
Cerebrovascular and Other Neurologic Complications of Kawasaki Disease (Chapter 6) - Uncommon Causes of Stroke
![Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5d113c51-9037-44ef-bf21-ef221a51cd49/gr1.gif)
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
![KAWASAKI DISEASE: CEREBROVASCULAR AND NEUROLOGIC COMPLICATIONS (Chapter 13) - Uncommon Causes of Stroke KAWASAKI DISEASE: CEREBROVASCULAR AND NEUROLOGIC COMPLICATIONS (Chapter 13) - Uncommon Causes of Stroke](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20180929095626-26949-smallThumb-87437tbl13_1.jpg?pub-status=live)
KAWASAKI DISEASE: CEREBROVASCULAR AND NEUROLOGIC COMPLICATIONS (Chapter 13) - Uncommon Causes of Stroke
![KAWASAKI DISEASE: CEREBROVASCULAR AND NEUROLOGIC COMPLICATIONS (Chapter 13) - Uncommon Causes of Stroke KAWASAKI DISEASE: CEREBROVASCULAR AND NEUROLOGIC COMPLICATIONS (Chapter 13) - Uncommon Causes of Stroke](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20180929095626-92215-mediumThumb-87437tbl13_1.jpg?pub-status=live)